Skip to main content
Indofarma Tbk. logo

Indofarma Tbk. — Investor Relations & Filings

Ticker · INAF ISIN · ID1000068406 IDX Manufacturing
Open in API
Filings indexed 18 across all filing types
Latest filing 2020-12-31 Regulatory Filings
Country ID Indonesia
Listing IDX INAF

About Indofarma Tbk.

https://indofarma.id/

Indofarma, established in 1918, is a pharmaceutical and medical device company. It manufactures and sells a range of products including generic and branded drugs, natural extracts, and diagnostic items for domestic and international markets. The company also provides specialized services such as pharmaceutical and natural extract toll manufacturing, and equivalence testing through its laboratory. With an extensive distribution network, Indofarma supports national health programs by focusing on the supply of essential medicines and medical solutions.

Recent filings

Filing Released Lang Actions
INAF - FY 2020 - 0889 - S Penjelasan Perubahan Aset dan Liabilitas.pdf
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Financial Services Authority (OJK) explaining changes greater than 20% in total assets and liabilities in the company's annual consolidated financial statements for the year ended December 31, 2020. It references a previously submitted audited annual financial report dated April 26, 2021. The document provides detailed explanations for significant changes in financial statement line items but does not contain the full financial statements or the full annual report itself. The length is 3872 characters, which is relatively short and more consistent with an explanatory letter or regulatory filing rather than a full annual report. The document is not a certification letter, but an explanatory note to a regulatory body about the annual financial report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory explanation related to the annual report, not the annual report itself.
2020-12-31 Indonesian
INAF - FY 2020 - LK Audited INAF 2020 - Final Released.pdf
Annual Report Classification · 100% confidence The document contains detailed consolidated financial statements including statements of financial position, profit or loss, changes in equity, cash flows, and extensive notes. It also includes an independent auditor's report and a board of directors' statement. The presence of comprehensive financial data for the fiscal year ending December 31, 2020, and comparative data for 2019, along with the auditor's report, indicates this is a full annual report. The document length (15,000 characters) and content confirm it is not merely an announcement or certification but the actual report. Therefore, the document is classified as an Annual Report (10-K equivalent).
2020-12-31 Indonesian
INAF - FY 2020 - FinancialStatement-2020-Tahunan-INAF.pdf
Annual Report Classification · 100% confidence The document is titled 'Penyampaian Laporan Keuangan Tahunan' which translates to 'Submission of Annual Financial Report'. It contains detailed financial statements including statement of financial position, profit or loss, and other comprehensive income for the year ended 31 December 2020. The document includes auditor information, audit opinion (unqualified), and compliance with regulatory requirements. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or summary. Therefore, this document is the official Annual Report covering the company's full financial performance for the fiscal year 2020. FY 2020
2020-12-31 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.